Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

IND clearance for pharmacokinetic study of Nebido

March 14, 2006

Acadia presents new nonpeptidergic UII receptor agonists

March 14, 2006

CKD-501 well tolerated in healthy subjects

March 14, 2006

Approvable letter for Preos

March 13, 2006

Novartis executes license option with Emisphere for oral PTH

March 13, 2006

DITPA studied in new phase II trial to treat elevated cholesterol levels

March 13, 2006

Pharmacokinetics of KS-01017 formulations and administration routes compared

March 13, 2006

Recent patents impart novel agents for obesity and lipoprotein disorders

March 10, 2006

Kyorin's antidiabetic agent KRP-104 begins phase I

March 10, 2006

Reveromycin A shows potential for osteoporosis

March 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
NTX-819, a novel mGlu7 NAM for psychiatric disorders
BioWorld Science
Increasing evidence supports metabotropic glutamate mGlu7 receptor as a promising target in psychiatric disorders. Neurosterix Pharma Sarl has presented data on...
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...